Thus, in the current study, the authors examined serum LCN2 levels in obese patients with NAFLD as well as its change in a subgroup of patients after laparoscopic sleeve gastrectomy (LSG). The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatotic liver disease.